|Bid||7.50 x 900|
|Ask||9.04 x 800|
|Day's Range||8.93 - 9.34|
|52 Week Range||7.30 - 15.23|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.20|
Every investor in Nuvation Bio Inc. ( NYSE:NUVB ) should be aware of the most powerful shareholder groups. Generally...
Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported financial results for the third quarter ended September 30, 2021, and provided a business update.
With the second-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the third quarter of 2021. One of these stocks was Nuvation Bio Inc. (NYSE:NUVB). Is NUVB a good […]